Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
Public ClinicalTrials.gov record NCT00698646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16 Week Multi-center, Randomized, Double-blind Study to Evaluate Efficacy and Safety of Valsartan/Hydrochlorothiazide (HCTZ) Combination Therapy Compared to Patients Initiated With Valsartan Monotherapy or Hydrochlorothiazide (HCTZ) Monotherapy in Very Elderly Patients With Essential Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety and efficacy of initial treatment therapy with valsartan/hydrochlorothiazide (HCTZ) versus the initial treatment therapy with monotherapies (valsartan or HCTZ) in the very elderly patients (greater than or equal to 70 years) with stage 1 or 2 hypertension
Study identification
- NCT ID
- NCT00698646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 384 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 70 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Jun 2009 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- Apr 19, 2011
2008 – 2009
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative site | Birmingham | Alabama | — | — |
| Investigative site | Phoenix | Arizona | — | — |
| Investigative Site | Escondido | California | — | — |
| Investigative site | Fresno | California | — | — |
| Investigative site | Huntington Park | California | — | — |
| Investigative Sites | Pismo Beach | California | — | — |
| Investigative site | Miami | Florida | — | — |
| Investigative site | Ormond Beach | Florida | — | — |
| Investigative site | Conyers | Georgia | — | — |
| Investigative Site | Lexington | Kentucky | — | — |
| Investigative site | Portland | Maine | — | — |
| Investigative site | Las Vegas | Nevada | — | — |
| Investigative site | Buffalo | New York | — | — |
| Investigative site | Shelby | North Carolina | — | — |
| Investigative site | Carlisle | Ohio | — | — |
| Investigative site | Oklahoma City | Oklahoma | — | — |
| Investigative site | Erie | Pennsylvania | — | — |
| Investigative Site | Greer | South Carolina | — | — |
| Investigative Site | Taylors | South Carolina | — | — |
| Investigative site | St. George | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00698646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2011 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00698646 live on ClinicalTrials.gov.